Fulcrum Therapeutics (FULC) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.83
-0.72
-0.6
-0.49

Details

Expected EPS
-0.49
Actual EPS
-0.5
Surprise EPS
-0.01
Surprise Percent
+2.04%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.5 per share for Q4 2022.

0 Comments

Share your thoughts